UNSPSC 51203001: Lobenzarit

This classification denotes an antioxidant with the molecular formula C14H10ClNO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 915EE91P39, chemically known as 4-chlor-2,2-iminodibenzoesaiure but more generally known as lobenzarit, which bears US NIH Compound Identifier 3946. European Medicines Agency schedules Lobenzarit in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08543MIG. The term LOBENZARIT is an International Non-Proprietary Name.

UNSPSC 51203001 Lobenzarit, a Commodity code, shows substantial recent activity in state and local procurement of pharmaceutical and medical supply products, though the opportunities posted under this code reflect a broader pharmaceutical purchasing pattern than the code's narrow nominal scope suggests. State and local governments are buying generic and brand-name pharmaceuticals, naloxone and drug deactivation systems, over-the-counter products, and emergency medical supplies through competitive bidding processes. Issuing bodies include state health agencies, county health departments, municipal fire and rescue divisions, and cooperative purchasing alliances. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, and the Texas Health and Human Services Commission represent state-level repeat activity, while Seminole County, Florida and the City of Tampa, Florida show municipal and county-level demand. The mix spans direct-to-manufacturer prescription programs, cooperative purchasing agreements for multi-state distribution, emergency-response medical supplies, and community health initiatives supported by county and municipal budgets.

Recent opportunities posted under the code include Seminole County's IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually (posted June 30, 2026, due July 26, 2023—note the date discrepancy in the source), with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the City of Tampa's invitation to bid for medical and first aid supplies for the Tampa Fire Department Rescue Division (solicitation 26P00145, due March 13, 2026, estimated contract value $700,000.00), designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount not to exceed $10,000; MMCAP's RFP for generic multi-source pharmaceuticals and OTC products through authorized wholesalers (solicitation S1070000015802, due March 26, 2026, effective July 1, 2026); and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs (solicitation HHS0017013, posted April 3, 2026). Activity concentrates in Florida and Texas, with multi-state reach through MMCAP's cooperative purchasing vehicle.